CRISPR/Cas9 DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targeting

Courtney, D G ; Moore, J E ; Atkinson, S D ; Maurizi, E ; Allen, E H A ; Pedrioli, D M L ; McLean, W H I ; Nesbit, M A ; Moore, C B T

Gene therapy, 2016-01, Vol.23 (1), p.108-112 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível